Zim Laboratories logo

541400 - Zim Laboratories News Story

₹90.15 1.9  2.1%

Last Trade - 10:59am

Sector
Healthcare
Size
Micro Cap
Market Cap £13.9m
Enterprise Value £20.9m
Revenue £29.3m
Position in Universe 1619th / 3111

BRIEF-India's Zim Laboratories Posts Sept-Quarter Consol Profit

Mon 26th October, 2020 11:00am
Oct 26 (Reuters) - Zim Laboratories Ltd  ZIML.BO :
    * INDIA'S ZIM LABORATORIES -SEPT-QUARTER CONSOL PAT 11.9
MILLION
RUPEES VERSUS LOSS 6.1 MILLION RUPEES YEAR AGO
    * SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 880.3 MILLION
RUPEES
VERSUS 677.9 MILLION RUPEES

Source text for Eikon:  ID:nBSE9NRdpp 
Further company coverage:  ZIML.BO 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.